Ask the experts a question here.

Eric Yoshida

Session 1: Knowing Your Hepatitis ABC’s
Dr. Eric Yoshida

Professor of Medicine, University of British Columbia
Division of Gastroenterology, Vancouver General Hospital
Chair, CLF National Medical Advisory Committee
Chair, CLF BC Medical Advisory Committee
Chair, CLF LIVERight Health Forum

Dr. Eric Yoshida is a Professor of Medicine at the University of British Columbia.  He is also currently the President of the Medical Staff Association at the Vancouver General Hospital. He is the past Head of the Division of Gastroenterology at UBC and VGH, past President of Canadian Association for the Study of Liver Disease (CASL), and has the distinction of being CASL’s longest-serving Governing Board Member.  He is well known nationally and internationally, as he has published more than 320 papers in peer-reviewed journals in the area of liver disease and liver transplantation.  He is the founding editor-in-chief of the Canadian Liver Journal, the official journal of CASL, and was the co-editor-in-chief of the Canadian Journal of Gastroenterology and Hepatology (previously the official journal of CASL).  Dr. Yoshida is the founder of the Royal College of Physicians and Surgeons of Canada’s Diploma Program in Hepatology and is the past Chair of the Royal College subcommittee. He has received the Queen Elizabeth Diamond Jubilee Medal, the CASL Distinguished Service Award, the VGH Clinical Excellence Award, and the Order of British Columbia. Dr. Yoshida has served for almost a decade as the Chair of the Canadian Liver Foundation’s National Medical Advisory Committee. He has given lectures at the CLF’s LIVERight Health Forums and other public liver disease forums since 2002 abd contributed articles for the LIVERight Gala program magazines. He is one of the inaugural Fellows of the American Association for the Study of Liver Diseases (AASLD) and is the only adult hepatologist in BC with that distinction.

 

Session 2: The Hidden Risk of Fatty Liver from Diabetes
Dr. Giada Sebastiani

Associate Professor
Department of Medicine, McGill University

Dr. Giada Sebastiani is Associate Professor of Medicine at McGill University and Clinician Scientist at the Research Institute of McGill University Health Centre in Montreal, Canada. She provides clinical services in the Division of Gastroenterology and Hepatology. She received a medical degree and specialized in internal medicine at the University of Padua, Italy. She had training in clinical and basic research at Harvard Medical School (US), University College of London (UK), University of Bordeaux (France) and Lady Davis Institute for Medical Research (Montreal, Canada). Her work focuses on fatty liver disease, liver fibrosis and non-invasive diagnostic tools in liver disease, with a current focus on at-risk populations, including people living with HIV, diabetics, patients with inflammatory bowel diseases and women with polycystic ovary syndrome. She is author of over 110 articles in peer-reviewed journals (including Gastroenterology, Hepatology, Journal of Hepatology, Clinical Infectious Diseases; h-index=35, total number of citations>4,400), 16 book chapters, 180 conference publications at national and international congresses. She is founding and steering committee member of the Canadian NASH Network and panel member in the Consensus on Models of Care in NAFLD of the International Liver Foundation. Dr Sebastiani is the sole North American representative in the guidelines of the European AIDS Clinical Society. She has been invited speaker in 70 international congresses and universities, including European, Asian Pacific, Mexican, Italian and Canadian Associations for the Study of the Liver. She was awarded the prestigious Clinical Research Salary Award from Fonds Recherche Sante Quebec. Other honors include: honorary membership of the Romanian Association for the Study of the Liver; Emerging Stars in Hepatology Award (Asian Pacific Association for the Study of the Liver, 2010); Top 10 cited papers 2006-2008 Award by Journal of Hepatology – European Association for the Study of the Liver. 

 

Session 3: Cirrhosis – Symptoms, Causes, Stages, Diagnosis and Treatment
Dr. Natasha Chandok

Associate Director
Osler Hepatitis Center

Dr. Natasha Chandok completed her MD at the University of Ottawa and residency training in Internal Medicine and Gastroenterology at McMaster University. Thereafter, she completed a Hepatology fellowship at the Mayo Clinic in Rochester, Minnesota, followed by a Master’s in Public Health at the Bloomberg School of Public Health in Baltimore, Maryland.

Dr. Chandok’s clinical career started as an Assistant Professor of Medicine in the Division of Gastroenterology at the University of Western Ontario until 2013 when she established a Hepatology practice at William Osler Health System. Now an Adjunct Professor of Medicine at Western and Clinical Affiliate at the University of Manitoba, Dr. Chandok continues activities in research and education, having established a successful e-learning app, LearnTheLiver. She has published over 40 peer-reviewed articles to date and supervises and lectures medical students and residents of McMaster University. She has been instrumental in establishing a Hepatology Program at Osler.


Stephen ChungSession 4: You Have Liver Cancer…I have what?
Dr. Stephen Chung

Professor of Surgery, University of British Columbia
Past Head, Hepatobiliary & Pancreatic Surgery, Vancouver General Hospital

Dr. Stephen Chung is one of the most well respected hepatobiliary and liver transplant surgeons, both academically and clinically, at the University of British Columbia. He is a full Professor of Surgery, past Head of the Division of General Surgery, Founder and inaugural Head of the Hepatobiliary & Pancreatic Surgery Program, Vancouver General Hospital, and has published many papers in peer-reviewed journals in this area. Dr. Chung has received awards from Vancouver General Hospital for his scientific contributions to liver transplantation. He has been the honouree at the Canadian Liver Foundation, BC/Yukon Chapter’s LIVERight Gala and has received the Gift of Life Award from the Happy Liver Society. Dr. Chung has volunteered his time to provide lectures at the CLF’s LIVERight Health Forums for many years and has contributed articles for the LIVERight Gala Program Magazines.

Dr. Chung is a member of a number of scholarly societies including the Canadian Association of General Surgeons, the British Columbia Surgical Society, the American Society of Transplant Surgeons, the American Hepatopancreaticobiliary Association, the International Liver Transplantation Society, the Pacific Coast Surgical Association and the Society of University Surgeons.


Session 5: Liver Disease and Jaundice in Newborns
Dr. Richard Schreiber

Clinical Professor, Division of Gastroenterology, Hepatology and Nutrition
Department of Pediatrics, Faculty of Medicine, University of British Columbia
BC Children’s Hospital

Dr. Richard Schreiber is the senior liver specialist and Director of its pediatric liver transplant program. His clinical research interests include biliary atresia, pediatric viral hepatitis B and C, autoimmune hepatitis and liver transplant. He is co-founder of the Canadian Pediatric Hepatology Research Group, a national collaborative effort to research and help improve the care and outcome of Canadian children with liver disease. He was the lead investigator of a CIHR funded project to examine the feasibility of a home-based newborn screening program for biliary atresia using infant stool colour cards. He is co-director of the Canadian Biliary Atresia Registry (CBAR).


Session 6: Alcohol Related Liver Disease
Dr. Vladimir Marquez

Clinical Assistant Professor
Vancouver General Hospital

Dr. Vladimir Marquez is a gastroenterologist and transplant hepatologist at the Vancouver General Hospital. He has an undergraduate degree in biochemistry, medical degree and master’s in clinical epidemiology from McGill University. He did his internal medicine and gastroenterology residency at Laval University and his fellowship in transplant hepatology at University of British Columiba. His areas of interest include portal hypertension, liver failure and vascular liver diseases. He is also actively involved in the management of patients with hepatocellular carcinoma. His principal research interest is in clinical outcomes of liver transplantation, liver failure, portal hypertension and its complications.


Session 7: From the Journey of Hepatitis C Discovery to Nobel Prize
Dr. Michael Houghton

Director, Li Ka Shing Applied Virology Institute (LKSAVI)
Canada Excellence Research Chair (CERC) in Virology 2010-2017
Professor, Department of Medical Microbiology & Immunology, University of Alberta
2020 Nobel Prize Winner

Dr. Michael Houghton was the Canada Excellence Research Chair in Virology from 2010-2018 and is the Director of the Li Ka Shing Applied Virology Institute. He was jointly named the 2020 Nobel Prize winner in Physiology or Medicine along with Harvey J. Alter and Charles M. Rice in recognition of the discovery of the hepatitis C (HCV) virus.

Together with colleagues Qui-Lim Choo and George Kuo, and Daniel W. Bradley from the Centers for Disease Control and Prevention, they first discovered HCV in 1989. Dr. Houghton was co-author of a series of studies published in 1989 and 1990 that identified hepatitis C antibodies in blood, particularly among patients at higher risk of contracting the disease, including those who had received blood transfusions. This work led to the development of a blood screening test in 1990; widespread blood screening that began in 1992 with the development of a more sensitive test has since virtually eliminated hepatitis C contamination of donated blood supplies in Canada and around the world. He has also been working on a HCV vaccine for the last 30 years in the US & Canada.


Session 8: Liver Disease Q & A – Presented in Chinese
Dr. Peter Kwan

Associate Professor, University of British Columbia
Division of Gastroenterology, Vancouver General Hospital

Dr. Peter Kwan was born in Hong Kong. He came to Canada at a young age. He graduated from medical school at the University of Western Ontario and received his post-doctoral training at the University of British Columbia and the National Institute of Health in Bethesda, Maryland. He is currently a Clinical Associate Professor at the University of British Columbia and a liver specialist in the Division of Gastroenterology at the Vancouver General Hospital. Because he is one of few liver specialists who can speak Chinese, 80% of his patients are Chinese immigrants. As a result, he has a large hepatitis B practice and has worked tirelessly to promote hepatitis B awareness in the community and has been featured in the Chinese language media on many occasions. Dr. Kwan has participated in hepatitis B related research projects and is currently the primary investigator of “Hep Beware” a local hepatitis B epidemiologic study, funded by the Canadian Liver Foundation (CLF), BC/Yukon Chapter. Dr. Kwan has been a speaker at many CLF’s LIVERight Health forums over the years and has contributed to written articles for the LIVERight Gala program magazines.

Session 8: Liver Disease Q & A – Presented in Punjabi
Dr. Daljeet Chahal

Dr. Daljeet Chahal completed his bachelor’s degree at the University of Northern BC, and then completed his master’s and medical degrees through the University of British Columbia (BC). He completed his internal medicine training in Vancouver and is currently in the final year of gastroenterology fellowship. He will be completing his hepatology training at the Mount Sinai Hospital in New York and afterwards will return to practice medicine in BC. He hopes to establish a research focus in addition to clinical practice.


Valeriya ZaborskaLIVERight Health Forum Host:
Valeriya Zaborska

Valeriya is a fourth-year medical student at the University of British Columbia Faculty of Medicine. She holds a Bachelor’s Degree in Science in Biomedical Physiology from Simon Fraser University and has worked for the Canadian Liver Foundation (CLF), BC/Yukon Region as an administrator/fundraiser until 2016. Since then, she has volunteered for CLF events such as the annual LIVERight Gala, LIVERight Health Forum, and the Stroll for Liver. She also worked as a medical office assistant in a hepatology clinic and has contributed as a research assistant on multiple liver-related studies, including treatment for HCC, liver transplants, and HCV. During COVID-19, she worked as a Health Operations Navigator for 8-1-1 and is currently completing her third and fourth year of medicine. She is interested in a future career in internal medicine.


LIVERight Health Forum Guest Host:
Dr. Harjot Bedi – Punjabi Session

Dr. Harjot Bedi is an Internal Medicine resident at University of British Columbia (UBC). She completed her bachelor’s degree at Queen’s University and master’s degree at UBC, both specializing in Immunology. She also completed medical school at UBC and went on to obtain another master’s degree in health sciences, which combined her interest in epidemiology and global health. She has an interest in various fields of gastroenterology and has been involved in various research projects spanning topics, such as, inflammatory bowel disease, primary sclerosing cholangitis, viral and drug induced hepatitis, and cirrhosis. She envisions combining her interest in gastroenterology and global health in the future.


LIVERight Health Forum Guest Host:
Dr. Thomas Ho – Chinese Session

Dr. Thomas Ho obtained his Bachelor of Science (Pharmacy) 1976 and Doctor of Medicine Degree (1980) from the University of British Columbia. He has been practicing as a full service family physician since 1981. He was given special recognition by the College of Family Physicians of Canada for Care of the Elderly. He holds the rank of Clinical Professor in the Department of Family Practice at UBC, teaching medical students and residents. He has been a Physician Examiner for the Medical Council of Canada for many years. Dr. Ho actively participates in public health education initiatives, health forums, radio and television talk shows.

Join the Canadian Liver Foundation Mailing List

Sign up for our newsletter and stay up to date on the latest news, updates and resources for liver disease.

Join the Canadian Liver Foundation Mailing List

Sign up for our newsletter and stay up to date on the latest news, updates and resources for liver disease.